Trial Profile
Studying the metabolism of sorafenib (Nexavar) by OATP1B blockage in adult cancer patients. [Onderzoek naar het effect van OATP1B blokkade op de stofwisseling van sorafenib (Nexavar) bij volwassen patiënten met kanker.]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Acronyms SORA-RIFA
- 02 Jun 2015 Status changed from recruiting to completed as per Netherlands Trial Register.
- 30 Aug 2013 New source identified and integrated: European Clinical Trials Database record.
- 28 Aug 2013 New trial record